A coronary calcium score answers one question for intermediate-risk adults: does the plaque already in your arteries justify statin therapy before a heart attack forces the issue. Intermediate-risk adults' coronary calcium score testing is a low-dose CT scan that measures calcified plaque in the coronary arteries, run specifically to reclassify a fuzzy risk estimate into a real number. This segment already sits in a gray zone — a 10-year ASCVD risk between roughly 7.5% and 20%, calculated but not resolved by a standard lipid panel. The scan exists to break that tie with a picture of the arteries instead of another formula.
TL;DR
- A coronary calcium score of 0 signals low 10-year cardiac risk for adults 40-75 with intermediate ASCVD risk.
- Scores above 100 typically move a clinician toward statin therapy regardless of LDL cholesterol level.
- CAC scanning works best paired with an ApoB and Lp(a) blood test, not as a standalone verdict.
- ACC/AHA 2018 guidance targets this test at adults with borderline-to-intermediate risk, not everyone over 40.
- A quarterly Biomarker Audit folds CAC results into ongoing tracking instead of a one-time reading.
- CAC scoring is a tiebreaker for adults 40-75 whose 10-year ASCVD risk falls between roughly 7.5% and 20%, not a general screening test.
- A score of 0 buys a "warranty period" of roughly a decade of low cardiac event risk, provided other risk factors don't worsen.
- Scores of 100-399 typically start statin therapy conversations regardless of the LDL number.
- The scan only detects calcified plaque — it has a blind spot for soft, unstable plaque, so ApoB, Lp(a), and hs-CRP still matter.
- Recheck intervals depend on the score: 5-10 years after a 0, roughly 3-5 years after a 1-99, sooner with new risk factors.
Why this matters for intermediate-risk adults
A standard lipid panel can look acceptable in someone who is still building dangerous plaque, because LDL cholesterol measures a concentration, not the actual particle count doing the damage. An ApoB lab test counts those particles directly, and it's the reason ApoB, not LDL alone, sits inside GoodLife Health's Cardiometabolic Optimization Membership as a quarterly marker rather than an occasional add-on.
The 2018 ACC/AHA cholesterol guideline named coronary calcium scoring as the tiebreaker for adults 40 to 75 whose risk sits in that borderline-to-intermediate band — not a screening test for everyone, and not a substitute for lipid and inflammation labs. Researchers studying the Multi-Ethnic Study of Atherosclerosis (MESA) cohort describe a CAC score of zero as buying a "warranty period": a stretch of roughly a decade with a low likelihood of a cardiac event, provided the underlying risk factors don't get worse. That's a meaningful number for someone weighing a statin decision in 2026, but it's only useful once it's read alongside the rest of the metabolic picture — weight, blood sugar, and hormones included, since cardiometabolic optimization treats those as one system, not separate problems.
Calculate your baseline ASCVD risk score
Do this before you book anything. A coronary calcium score without a baseline risk number is a number with no context to sit inside.
- Use the ACC/AHA Pooled Cohort Equations calculator — free, no signup, published by the American College of Cardiology
- Enter age, sex, total and HDL cholesterol, systolic blood pressure, smoking status, and diabetes status
- Flag risk-enhancing factors separately: family history of early heart disease, chronic kidney disease, or an inflammatory condition
- Note where you land: under 5% is low risk, 5-7.4% is borderline, 7.5-20% is intermediate, over 20% is high
- If you fall in the borderline or intermediate band, a coronary calcium score becomes clinically relevant; outside that band, most 2026 guidance still doesn't recommend it as a routine next step
Pull the labs that change the picture
The scan means more with data around it. Order these before or alongside scheduling.
- A standard lipid panel: total cholesterol, LDL, HDL, triglycerides
- An ApoB lab test, since it catches atherogenic particles that LDL alone can undercount
- A Lp(a) blood test once, since it's genetically set and rarely needs reordering after a baseline
- An hs-CRP draw if there's any sign of chronic inflammation
- A comprehensive Biomarker Audit — the kind repeated every 90 days inside GoodLife Health's Cardiometabolic Optimization Membership — runs all four in one draw instead of four separate orders across two providers
Schedule the scan itself
This step is administrative, not medical. Most adults can do it without waiting on a specialist referral.
- Search for imaging centers or hospital cardiology departments listing "coronary calcium scoring" or "CAC scan" by name
- No referral is required at most facilities; self-pay is standard since many insurers still classify it as a screening test
- The scan itself takes about 10 to 15 minutes and uses no IV contrast
- Radiation exposure is low, roughly comparable to a mammogram
- Confirm the report lists the raw Agatston score by artery, not only a single composite number
Read your Agatston score correctly
The number on the report only means something once you know the bands it falls into.
- A score of 0 places you in the lowest risk category for roughly the next decade, assuming risk factors don't worsen
- A score of 1-99 signals early plaque; most clinicians pair this with lifestyle change and closer lipid monitoring
- A score of 100-399 is where statin therapy conversations typically start, regardless of what the LDL number says
- A score of 400 or higher indicates extensive calcified plaque and usually triggers more aggressive lipid and blood pressure targets
- Remember the blind spot: the scan only sees calcified plaque, not the soft, unstable plaque that can rupture without ever showing up as a number
Decide on treatment intensity with your clinician
This is where the scan and the labs need to sit in the same conversation, not two separate ones.
- Bring the CAC report to the same visit as your ApoB, Lp(a), and hs-CRP blood test results
- A high hs-CRP alongside a positive CAC score points toward inflammation as an added driver, not just cholesterol
- Ask specifically whether the score changes your ApoB target, not just whether you "need a statin"
- If Lp(a) is elevated and the CAC score is also positive, treatment intensity usually moves up a notch, since standard statins don't lower Lp(a) itself
- Inside a Cardiometabolic Optimization Membership, one clinician reads all four data points on the same quarterly cycle, instead of a cardiologist reading the scan and a separate primary care doctor reading the labs months later
A high hs-CRP alongside a positive CAC score points toward inflammation as an added driver, not just cholesterol — and if Lp(a) is also elevated, treatment intensity usually moves up a notch, since standard statins don't lower Lp(a) itself.
Set your recheck interval
A coronary calcium score is not an annual habit. The blood markers between scans are.
- A score of 0 with stable risk factors typically doesn't need a repeat scan for 5-10 years
- A score of 1-99 is often rechecked around the 3-5 year mark
- New diabetes, new smoking, or significant weight gain shortens that interval
- The markers that predict progression — ApoB, Lp(a), hs-CRP, HbA1c — are worth tracking more often than the scan itself
- A quarterly Biomarker Audit tracks what moves between scans, so the CAC result isn't the only signal you're watching for years at a stretch
Comparing your options
Comparing your options
| Option | Best for | Key limitation | Verdict |
|---|---|---|---|
| Coronary calcium score (CAC) alone | Adults 40-75 with intermediate ASCVD risk wanting a one-time snapshot | Doesn't detect soft, non-calcified plaque | Buy for risk reclassification, not as proof of a clean bill of health |
| Standard lipid panel only | Adults with clearly low or clearly high risk who don't need imaging | Misses a large share of at-risk patients whose LDL looks normal | Skip as the sole test for intermediate-risk adults |
| CAC plus ApoB, Lp(a), and hs-CRP panel | Intermediate-risk adults who want the scan read in context | Usually requires coordinating two separate visits unless bundled | Buy — this is the combination most guideline authors describe |
| Coronary CT angiography (CCTA) | Adults with chest pain symptoms or a very high CAC score needing more detail | Requires IV contrast and higher radiation than CAC alone | Hold for symptomatic or high-score follow-up, not routine screening |
A coronary calcium score answers one question for intermediate-risk adults: does the plaque already in your arteries justify statin therapy before a heart attack forces the issue.
Common mistakes intermediate-risk adults make
- Treating a score of 0 as permanent immunity and dropping lipid monitoring altogether afterward
- Getting the scan before calculating a baseline ASCVD risk score, so the result has no context to sit inside
- Skipping the ApoB and Lp(a) blood test draw and treating the CAC number as the whole risk picture
- Waiting on insurance prior authorization for a test that's usually self-pay and available the same week
- Repeating the scan every year "to check progress" instead of tracking the blood markers that actually move between scans
FAQ
What is a good coronary calcium score?
A coronary calcium score of 0 is the best result and signals low cardiac risk for roughly the next decade. Scores of 1-99 are considered mild, and anything above 100 usually shifts a clinician toward statin therapy.
Who should get a CAC scan?
Adults age 40-75 with an intermediate 10-year ASCVD risk (roughly 7.5% to 20% on the pooled cohort calculator) are the group most guidelines target. Outside that band, the scan usually doesn't change the treatment decision.
Is a coronary calcium score covered by insurance?
Most insurers classify CAC scanning as a screening test, so coverage is inconsistent and many adults pay out of pocket regardless of their eventual score. Confirm with the imaging center directly before scheduling.
How much radiation does a CAC scan involve?
The radiation dose from a coronary calcium score is low, roughly comparable to a mammogram. No IV contrast is used, and the scan itself takes about 10 to 15 minutes.
Can a coronary calcium score be zero and still carry heart disease risk?
Yes. The scan only detects calcified plaque, so soft, non-calcified plaque can be present and unstable even with a score of 0. That's why ApoB and Lp(a) results still matter alongside a zero score.
How often should you repeat a coronary calcium score?
A score of 0 with stable risk factors is often not repeated for 5-10 years. A score of 1-99 is more commonly rechecked around the 3-5 year mark, sooner if new risk factors appear.
Is a coronary calcium score the same as a coronary CT angiography?
No. A CAC scan measures calcified plaque without contrast dye, while a coronary CT angiography (CCTA) uses IV contrast to visualize the arteries in more detail, including soft plaque. CCTA is typically reserved for symptomatic patients or very high CAC scores.
What labs should accompany a coronary calcium score?
A lipid panel, an ApoB test, a one-time Lp(a) test, and hs-CRP give a clinician the context to interpret the score. Without them, a CAC number sits on its own with no clear next step.
One last thing
Lp(a) doesn't show up on a routine lipid panel unless it's specifically ordered, and most adults go their entire life without one. It's worth requesting even after a coronary calcium score of 0, because Lp(a) is set genetically at birth and predicts future plaque formation rather than reflecting what's already calcified today. A clean scan paired with an unmeasured Lp(a) is an incomplete answer, not a finished one, going into 2026 risk conversations.
Related guides
- Lipid panel explained: what each number means for your heart
- How to lower ApoB with diet, lifestyle, and medication
- hs-CRP blood test: what high inflammation means
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/